Vaccine against cancer diseases that are associated with the her-2/neu oncogene

作者: Erika Jensen-Jarolim , Christoph Zielinski , Otto Scheiner , Hubert Pehamberger , Heimo Breiteneder

DOI:

关键词: ConjugateHer 2 neu oncogeneExtracellularTransfectionImmune systemDiagnostic methodsNucleic acidBiologyMolecular biologyCancerBiochemistry

摘要: The present invention relates to peptides of the extracellular domain a HER-2/neu protein, conjugates comprising said linked an immunogenic carrier, compositions thereof, nucleic acid molecules, vectors and transformed or transfected host cells molecules encoding conjugates, methods for producing disclosed peptides, compositions. also diagnostic detecting cancerous conditions associated with monitoring effectiveness treatment against HER-2/neu. eliciting enhancing immune response in subject need thereof.

参考文章(38)
Donna Woodbine, Naveen Dakappagari, Pierre Triozzi, Vernon Stevens, Pravin T. P. Kaumaya, Biological effects of peptide antibodies raised to HER-2/neu. Implications for therapy of human breast cancer Springer Netherlands. pp. 779- 780 ,(2002) , 10.1007/0-306-46862-X_339
Pravin T. P. Kaumaya, Vernon C. Stevens, Pierre L. Triozzi, Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein ,(2000)
Gert Riethmüller, Christina R. M. Kentenich, Wolfgang Janni, Florian Hepp, Klaus Pantel, Harald L. Sommer, Fritz Willgeroth, Stephan Braun, Monoclonal Antibody Therapy with Edrecolomab in Breast Cancer Patients: Monitoring of Elimination of Disseminated Cytokeratin-positive Tumor Cells in Bone Marrow Clinical Cancer Research. ,vol. 5, pp. 3999- 4004 ,(1999)
H. Michael Shepard, Robert Michael Hudziak, Axel Ullrich, Her2 extracellular domain. ,(1990)
Martin Gramatzki, Wolfgang Hiddemann, David M. Goldenberg, Bernhard Wörmann, Wolfgang Becker, Stefan Gratz, Joachim Riggert, Robert M. Sharkey, Thomas M. Behr, Frank Griesinger, Martin Béhé, Hans-J. Kolb, Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies. Clinical Cancer Research. ,vol. 5, ,(1999)